Patient and Public Involvement
Published Materials
📑 Published Papers
Nobutaka Yagi, Hayley CHapman, Masumi Hoshiyama, Tatsuki Ishizuka, Yoshiyuki Majima, Katsumasa Nagano, Masaki Okuse, Shunsuke Suzuki, Shun Tezuka, Kotone Matsuyama. Proceedings: The 1st Roundtable on Patient Participation and Patient Experience Data (PED) in Japan: Towards the Systematic Implementation of PED. Clinical Evaluation. 2026;53(3):459-71 (Original English version: W1-16 ).
Nobutaka Yagi, Kotone Matsuyama, Kenma Nozaki, Masumi Hoshiyama, Keiko Omomo, Takahiro Inoue. Clinical Trial Ambassadors (Initiatives to support appropriate understanding of clinical trials and patients' decision-making regarding participation in clinical trials). Abstracts of the Annual Meeting of the Japanese Society of Clinical Pharmacology. 2023;44: Session ID 44_3-CP-D3 of the 44th Annual Meeting of the Japanese Society of Clinical Pharmacology. https://doi.org/10.50993/jsptsuppl.44.0_3-CP-D3
Yuta Kawanishi, Kenma Nozaki, Nobutaka Yagi, Shintaro Omuro, Keiko Omomo, Kotone Matsuyama. A Patient Training Initiative for Pharmaceutical Development: The "Clinical Trial Ambassador Project" and Future Challenges – Developing a Social Infrastructure for Pharmaceutical Development that Utilizes Patient Voices. Clinical Pharmacology. 2023;54(4):173-180.
https://doi.org/10.3999/jscpt.54.4_173
Matsuyama, Kotone. Patient Public Involvement in Clinical Trials and its Future Prospects. Abstracts of the Annual Meeting of the Japanese Society of Clinical Pharmacology. 2022;43: Session ID 43_3-C-EL09-2, 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology.
https://doi.org/10.50993/jsptsuppl.43.0_3-C-EL09-1
Nobutaka Yagi. Why are clinical trial ambassadors necessary? – Background and expectations for their role. Abstracts of the Annual Meeting of the Japanese Society of Clinical Pharmacology. 2022;43: Session ID 43_3-C-EL09-2, 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology.
https://doi.org/10.50993/jsptsuppl.43.0_3-C-EL09-2
Kasai Yuta, Matsuyama Kotone, Yagi Nobutaka. Patient Public Involvement in Clinical Trials: Clinical Trial Ambassadors' Efforts as Co-Creation of Drug Development with Patient Groups . Abstracts of the 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology and Medicine. 2022;43:Session ID 43_3-C-EL09-3 of the 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology and Medicine.
https://doi.org/10.50993/jsptsuppl.43.0_3-C-EL09-3
🔊 Presentations for Academic Conferences and Seminars
16th Annual Meeting of the Japanese Society of Pharmaceutical Medicine, IFAPP Session. July 26, 2025.
IRBees Seminar 3, FY2025: What is PPI? July 24, 2025.
Pharmaceutical Research and Manufacturers of America (PhRMA) Study Session. May 16, 2025.
Pharma IT 2025 Seminar: The Potential of Patient Experience Data and Online Patient Communities. How to utilize patient experience data (data that conveys patient experiences) in drug development and healthcare settings . April 10, 2025.
The 16th Annual Meeting of the Japanese Society for Clinical Trials. Symposium 22. New Communication Design through the Utilization of VR/MR to Ensure Diversity in Clinical Trials. Utilization of the Metaverse as a New Touchpoint with Patients: Towards the Construction of Sequential and Sustainable Patient Experience Data. March 1, 2025.
The 16th Annual Meeting of the Japanese Society for Clinical Trials. Luncheon Seminar 6. Borderless: Beyond the Boundaries of Medical Institutions. The Clinical Trial Ambassador Project: Achieving a Patient-Centered Approach. February 28, 2025.
Osaka Rare Disease Consultation and Support Center Project: Citizens' Gathering Symposium - What We Can Do to Ensure Medications Arrive Quickly: Eliminating Misunderstandings Between Different Knowledge Bases. Lecture 2 : Understanding Clinical Trials - Activities of Clinical Trial Ambassadors - Turning Knowledge into Power - What We Can Do from Various Positions . February 22, 2025.
Osaka University Hospital, FY2024 Clinical Trials and Ethics Review Committee Member Training. Lecture 3. Initiatives of Patient Support Groups. February 22, 2025.
The 45th Annual Meeting of the Japanese Society of Clinical Pharmacology. Symposium 20. Patient and Public Involvement (PPI) in Clinical Research. The Value of Patient Experience Data and Open Innovation Starting from Patient and Public Participation. December 13, 2024.
The 65th Annual Meeting of the Japan Lung Cancer Society. Patient Advocate Program, Lecture 6: Understanding Clinical Trials – Activities of Clinical Trial Ambassadors . November 1, 2024.
21st DIA Japan Annual Meeting 2024. Short Course 1 : Patient Experience Data (PED) – Value and Application in Pharmaceutical Development . October 28, 2024.
The 21st DIA Japan Annual Meeting 2024. Session 21: Promoting Plain Language Summaries for Mutual Understanding. The Role of Plain Language Summaries (PLS) in Social Co-creation: Global and Japanese Current Situations, and Their Ethical Perspectives . October 28, 2024.
40th Research Conference of the National Rare Disease Center Research Group. Panel 5. Initiatives to Realize Patient and Citizen Participation Linked to Social Co-creation: From Clinical Trial Ambassadors to YORIAILab . September 28, 2024.
ARO Council 11th Academic Conference. Oral Presentation 1. Current status and examples of initiatives to realize patient-citizen engagement that stimulates social co-creation . September 20, 2024.
1st Behavioral Science and Survivorship Seminar, 2024. PPI (Patient and Public Involvement) - Let's think about the value we can create together . June 26, 2024.
15th Annual General Meeting of the Japan Society for Clinical Trials and Clinical Trials. Luncheon Seminar 1: Considering the clinical trial environment from the perspective of patient and citizen participation - To build healthcare evidence from a wider range of perspectives. "Learning together" about clinical trials: What the Clinical Trial Ambassador Project creates for society . March 8, 2024.
The 44th Annual Meeting of the Japanese Society of Clinical Pharmacology. Poster Presentation. Clinical Trial Ambassador (Initiatives to support proper understanding of clinical trials and patients' decision-making regarding clinical trial participation) . December 14-16, 2023.
The 39th Research Conference of the National Rare Disease Center Research Group. Panel 2. Patient and Public Involvement (PPI) in Drug Development and the Initiatives of Clinical Trial Ambassadors: Social Co-Creation to Properly Understand Clinical Trials and Lead to Patient Decision-Making . December 7, 2023.
The 23rd Conference on CRC and Clinical Trials 2023. Co-hosted seminar 5 Clinical Trial Ambassadors (efforts to support proper understanding of clinical trials and patients' decision-making to participate in clinical trials). Why are clinical trial ambassadors necessary? . September 16, 2023.
The 23rd Conference on CRC and Clinical Trials 2023. Co-hosted Seminar 5 Clinical trial ambassadors (efforts to support proper understanding of clinical trials and patients' decision-making to participate in clinical trials). What clinical trial ambassadors expect from CRCs, and their impact on clinical trials and consent acquisition . September 16, 2023.
Juntendo University Immunotherapy Research Center Public Lecture. Session: A message to patients and citizens participating in medical research and clinical trials - To deliver research results to patients and their families - A new initiative between patients and pharmaceutical companies: Clinical Trial Ambassador Project . March 19, 2023.
43rd Annual Meeting of the Japanese Society of Clinical Pharmacology. Educational Lecture 9 : Patient Public Involvement in Clinical Trials - Clinical Trial Ambassadors' Efforts as Co-Creation of Drug Development with Patient Groups . Why are clinical trial ambassadors needed? The background and expectations for their role . December 2, 2022.
43rd Annual Meeting of the Japanese Society of Clinical Pharmacology. Educational Lecture 9 : Patient Public Involvement in Clinical Trials - Clinical Trial Ambassadors' Efforts as Co-Creation of Drug Development with Patient Groups . Patient Training Package for Raising Awareness of Clinical Trials and Issues in Their Operation . December 2, 2022.
43rd Annual Meeting of the Japanese Society of Clinical Pharmacology. Educational Lecture 9 : Patient Public Involvement in Clinical Trials - Clinical Trial Ambassadors' Efforts as Co-Creation of Drug Development with Patient Groups. Patient Public Involvement in Clinical Trials and Its Future Outlook . December 2, 2022.
🗃️Related materials
Matsuyama K, Tsutsumi N, Inoue K, Iwaya N, Imamura K. Patient and public involvement (PPI) and pharmaceutical development through open innovation processes: recent activities. In: Kurihara C, Greco D, Dhai A, , editors. Ethical Innovation for Global Health: Pandemic, Democracy and Ethics in Research. Singapore: Springer (2023), p. 297–312.
https://link.springer.com/chapter/10.1007/978-981-99-6163-4_16
Matsuyama K, Tsutsumi N, Inoue K, Iwaya N, Imamura K. Patient and public involvement (PPI) and pharmaceutical development through open innovation processes: recent activities. In: Kurihara C, Greco D, Dhai A, , editors. Ethical Innovation for Global Health: Pandemic, Democracy and Ethics in Research. Singapore: Springer (2023), p. 297–312.
https://link.springer.com/chapter/10.1007/978-981-99-6163-4_16
Matsuyama K, Tsutsumi N, Inoue K, Iwaya N, Imamura K. Patient and public involvement (PPI) and pharmaceutical development through open innovation processes: recent activities. In: Kurihara C, Greco D, Dhai A, , editors. Ethical Innovation for Global Health: Pandemic, Democracy and Ethics in Research. Singapore: Springer (2023), p. 297–312.
https://link.springer.com/chapter/10.1007/978-981-99-6163-4_16